Thomas G. Lynch, Director at Evofem Biosciences, Inc. (EVFM), bought 200,000 shares at $2.33 ($452K) on 2018-08-15, disclosed to the SEC on 2018-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 31,071 | $65K | 14.4% |
| 2 | $2.10 | 31,071 | $65K | 14.4% |
| 3 | $2.33 | 68,929 | $161K | 35.6% |
| 4 | $2.33 | 68,929 | $161K | 35.6% |
| Total | $2.26 avg | 200,000 | $452K | 100% |